XORTX Announces Participation in Spring 2024 Investor Conferences
April 08, 2024 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical...
Pineapple Energy Encourages Shareholders to Vote FOR the Reverse Stock Split and Increase in Authorized Shares
April 08, 2024 07:00 ET
|
Pineapple Energy
Pineapple Energy Encourages Shareholders to Vote FOR the Reverse Stock Split and Increase in Authorized Shares
Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
April 08, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
New preclinical data on novel E3 pairing and structural mechanisms for KT-333, a First-in-Class STAT3 degrader, presented in AACR’s late-breaking poster session Nello Mainolfi, Founder, President and...
Flagship Communities Real Estate Investment Trust to Host Conference Call for First Quarter 2024 Results
April 08, 2024 07:00 ET
|
Flagship Communities Real Estate Investment Trust
Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, April 08, 2024 (GLOBE NEWSWIRE) -- Flagship Communities Real Estate Investment Trust (TSX:...
Martin Marietta Completes Acquisition of Aggregates Operations From Affiliates of Blue Water Industries LLC and Announces First-Quarter 2024 Earnings Conference Call
April 08, 2024 06:55 ET
|
Martin Marietta Materials, Inc.
RALEIGH, N.C., April 08, 2024 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE: MLM) (Martin Marietta or the Company) today announced that, on April 5, 2024, it completed its previously...
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
April 08, 2024 06:00 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
April 07, 2024 16:00 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., April 07, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the oral plenary session presentation of positive pivotal data from the Phase 1/2...
Mohawk Industries, Inc. 诚邀您参与 2024 年第一季度盈利网上电话会议
April 06, 2024 13:43 ET
|
Mohawk Industries, Inc.
佐治亚州，卡尔霍恩, April 07, 2024 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) 将于 2024 年 4 月 25 日星期四公布 2024 年第一季度盈利业绩。诚邀您收听将于 2024 年 4 月 26 日星期五上午 11:00（美国东部时间）现场网上广播的电话会议。 内容：Mohawk Industries,...
Mohawk Industries, Inc. le invita a unirse a la teleconferencia sobre los resultados del primer trimestre de 2024
April 06, 2024 13:43 ET
|
Mohawk Industries, Inc.
CALHOUN, Georgia, April 06, 2024 (GLOBE NEWSWIRE) -- Coincidiendo con la publicación por parte de Mohawk Industries, Inc. (NYSE: MHK) de los resultados correspondientes al primer trimestre de 2024...
Mohawk Industries, Inc. la invita a partecipare alla videoconferenza sugli utili del primo trimestre 2024
April 06, 2024 13:43 ET
|
Mohawk Industries, Inc.
CALHOUN, Ga., April 06, 2024 (GLOBE NEWSWIRE) -- In occasione della presentazione degli utili del primo trimestre 2024 di Mohawk Industries, Inc. (NYSE: MHK), giovedì 25 aprile 2024, la invitiamo a...